| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | General Counsel And Secretary
2 companies
Meisner Lara is a Chief Legal Officer at Bicara Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | BCAX Bicara Therapeutics Inc. | Chief Legal Officer | Sale+OE | 33,807 | $14.75 | $498,653.25 | -100% | +19.0% | - | |
| Sep 15, 2025 | BCAX Bicara Therapeutics Inc. | Chief Legal Officer | Sale+OE | 15,829 | $11.49 | $181,875.21 | -100% | +61.3% | - | |
| Jun 16, 2025 | BCAX Bicara Therapeutics Inc. | Chief Legal Officer | Sale+OE | 15,829 | $10.43 | $165,096.47 | -100% | +13.8% | - | |
| Mar 14, 2025 | BCAX Bicara Therapeutics Inc. | Chief Legal Officer | Sale+OE | 79,146 | $12.90 | $1,021,210.80 | -72.1% | -6.8% | +54.5% | |
| Jun 16, 2023 | VRDN Viridian Therapeutics, Inc.\de | Chief Legal Officer | Sale+OE | 2,296 | $28.02 | $64,342.83 | -3.7% | -35.4% | -54.1% | |
| Jun 6, 2023 | VRDN Viridian Therapeutics, Inc.\de | Chief Legal Officer | Sale+OE | 7,500 | $24.82 | $186,136.24 | -7.7% | -22.6% | -50.6% | |
| Mar 9, 2023 | VRDN Viridian Therapeutics, Inc.\de | General Counsel And Secretary | Sell | 29,971 | $29.07 | $871,256.97 | -100% | -14.2% | -34.7% | |
| Jan 23, 2023 | VRDN Viridian Therapeutics, Inc.\de | General Counsel And Secretary | Sale+OE | 6,843 | $35.66 | $244,021.38 | -100% | -18.4% | -46.9% | |
| Dec 21, 2022 | VRDN Viridian Therapeutics, Inc.\de | General Counsel And Secretary | Sale+OE | 16,926 | $29.15 | $493,397.94 | -100% | -9.5% | -27.7% | |
| Dec 16, 2022 | VRDN Viridian Therapeutics, Inc.\de | General Counsel And Secretary | Sale+OE | 1,597 | $28.37 | $45,310.68 | -100% | +2.6% | -31.1% |